Medical Diagnostics & Clinical Scoring

Gail Model Breast Cancer Risk

Estimate a woman's 5-year and lifetime risk of developing invasive breast cancer using the validated Gail Model criteria.

Relative Risk Index
1.00
Clinical AssessmentAverage Risk

Calculated locally in your browser. Fast, secure, and private.

Gail Model (BCRAT) Overview

The Gail Model, formally known as the Breast Cancer Risk Assessment Tool (BCRAT), is a highly validated statistical algorithm designed to estimate a woman's absolute risk of developing invasive breast cancer over the next 5 years and up to age 90 (lifetime risk).

Clinical Application

The model is primarily used by physicians to:

  • Identify women at high risk who may benefit from enhanced screening protocols (like adding breast MRI to annual mammography).
  • Determine eligibility for chemoprevention strategies (using medications like tamoxifen or raloxifene to reduce risk).
  • Provide objective data to guide patient counseling and alleviate anxiety for women at lower risk.

Key Risk Factors Evaluated

The Gail Model calculates risk based on a combination of demographic and reproductive history:

  1. Current Age: Risk increases with age.
  2. Age at Menarche: Early onset of menstruation (before age 12) increases lifetime estrogen exposure and risk.
  3. Age at First Live Birth: Having a first child after age 30, or being nulliparous, increases risk.
  4. Family History: The number of first-degree female relatives (mother, sisters, daughters) diagnosed with breast cancer.
  5. Biopsy History: The number of previous breast biopsies, specifically assessing whether any showed atypical hyperplasia.
  6. Race/Ethnicity: The model adjusts baseline risks based on epidemiological data for different racial groups.

Absolute Risk = Mathematical probability based on cumulative relative risks

Frequently Asked Questions

A 5-year risk of 1.67% or higher is historically considered the threshold for 'high risk.' This is the cutoff often used in clinical trials to determine if a woman is eligible for risk-reducing medications.

The model is invalid and should not be used for women who already have a diagnosis of breast cancer, LCIS, or DCIS. It also drastically underestimates risk for women with known high-risk genetic mutations (like BRCA1 or BRCA2) or a history of radiation therapy to the chest.

No. The standard Gail model does not include breast density or family history on the father's side, nor does it include second-degree relatives. Other models, like the Tyrer-Cuzick (IBIS) model, incorporate these broader factors.